• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Valneva Se ADR (NQ: VALN )

    5.480 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 7, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Valneva Se ADR

    < Previous 1 2
    ...
    4 5 6 7 8 9 10 11 Next >
    Why Valneva's Shares Are Plunging Today Premarket
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    Welcome back and get ready for another busy week of trading as we start it off with the biggest pre-market stock movers for Monday! 
    Via InvestorPlace
    Stocks That Hit 52-Week Lows On Wednesday
    On Wednesday, 807 companies reached new 52-week lows. 
    Via Benzinga
    How To Attend Valneva Q1 2022 Earnings Conference Call
    Valneva (NASDAQ:VALN) will host a conference call at 09:00 AM ET on May 5, 2022, to discuss Q1 2022 earnings results. How to Attend Valneva (VALN) Conference Call Follow this link to access the live... 
    Via Benzinga
    Valneva - Pfizer Post Encouraging Data From Lyme Disease Vaccine Candidate
    Via Benzinga
    Valneva Shares Jump As Its COVID-19 Vaccine Receives Conditional Approved In UK
    Via Benzinga
    Read Why Valneva's Stock Gained 7% Today
    Valneva SE (NASDAQ: VALN) completed the Phase 3 pivotal trial of its single-shot chikungunya vaccine candidate, VLA1553. Valneva posted topline results ... 
    Via Benzinga
    The Daily Biotech Pulse - Tuesday, April,26
    Here's a roundup of top developments in the biotech space over the last 24 hours. 
    Via Talk Markets
    The Daily Biotech Pulse: Protagonist's Ulcerative Colitis Study Disappoints, Gilead's Remdesivir Approved For Pediatric COVID-19 Patients, FDA Gives Nod To Gamida's Cell Therapy Trial, Fast Track Tag For Vascular Biogenics Ovarian Cancer Gene Therapy
    Here's a roundup of top developments in the biotech space over the last 24 hours: 
    Via Benzinga
    Valneva and Pfizer Report Positive Phase 2 Pediatric Data for Lyme Disease Vaccine Candidate
    From Pfizer Inc.
    Via Business Wire
    Why Are Valneva Shares Rising Today Premarket?
    Valneva SE (NASDAQ: VALN) expects its COVID-19 vaccine candidate to boost its sales in FY22 considerably, after  
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Valneva Receives More Questions From European Regulator For Its COVID-19 Vaccine, Shares Fall
    Via Benzinga
    Britain Approves Moderna's COVID-19 Vaccine For Kids Aged 6-11 Years
    Via Benzinga
    The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Booster Data In Kids, Regeneron's COVID-19 Therapy Decision Pushed, Protagonist's Rusfertide Breakthrough Tag Update And More
    Here's a roundup of top developments in the biotech space over the last 24 hours: 
    Via Benzinga
    Earnings Scheduled For March 24, 2022
    Companies Reporting Before The Bell • iHuman (NYSE:IH) is likely to report earnings for its fourth quarter. • Pioneer Muni High Inc (NYSE:MAV) is expected to... 
    Via Benzinga
    European Recommendation On Valneva's COVID-19 Shot Pushed Into April
    Valneva SE (NASDAQ: VALN) now expects a positive recommendation from the European Medicines Agency (EMA) for its VLA2001 COVID-19 candidate vaccine in April. Earlier,... 
    Via Benzinga
    The Daily Biotech Pulse: Valneva Gains On COVID Shot Regulatory Update, Lucira Health And Clearside Jump On Earnings, BeiGene Drug Snags Approval In China
    Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Valneva Says Confident Of Conditional Approval For COVID Vaccine Candidate In... 
    Via Benzinga
    The Daily Biotech Pulse: Moderna Outlines Steps For mRNA Tech Advancement, Voyager-Novartis Strike Licensing Deal, Valneva Reports Positive Chikungunya Shot Readout
    Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Moderna Announces 4 Initiatives To Advance mRNA Vaccines As Preventative... 
    Via Benzinga
    42 Stocks Moving in Monday's Pre-Market Session
    Gainers Nine Energy Service, Inc. (NYSE: NINE) rose 96.7% to $3.54 in pre-market trading after climbing around 43% on Friday. Shares of low-priced energy stocks jumped as... 
    Via Benzinga
    76 Biggest Movers From Yesterday
    Gainers Houston American Energy Corp. (NYSE: HUSA) surged 494.7% to close at $11.30 on Monday amid continued momentum and an increase in the price of oil. Imperial Petroleum Inc... 
    Via Benzinga
    The Daily Biotech Pulse: Legend Biotech, CTI Biopharma Receive FDA Approvals, AbbVie Announces Delay In Skyrizi Review, Editas Gains On CRISPR Patent Resolution
    Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Editas Gains On Resolution Of CRISPR Gene Editing Patent Case Editas Medicine... 
    Via Benzinga
    46 Stocks Moving In Monday's Mid-Day Session
    Gainers Houston American Energy Corp. (NYSE: HUSA) jumped 137.4% to $4.5150 amid continued momentum and an increase in the price of oil. Imperial Petroleum Inc. (NASDAQ:... 
    Via Benzinga
    The Daily Biotech Pulse: Lilly's Jardiance Gets Nod For Heart Failure, Pulmatrix Announces Reverse Split, Reata Awaits FDA Decision
    Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Lilly's Co-developed Diabetes Drug Jardiance Gets Label Expansion To... 
    Via Benzinga
    Valneva Secures £20M From Scottish Enterprise For Vaccine Development
    Valneva SE (NASDAQ: VALN) has been awarded research and development funding of up to £20 million by Scottish Enterprise. The investment from Scotland's... 
    Via Benzinga
    Valneva - Pfizer Choose Three-Dose Schedule For Lyme Vaccine Candidate Moving Forward
    Valneva SE (NASDAQ: VALN) and Pfizer Inc (NYSE: PFE) have  
    Via Benzinga
    The Daily Biotech Pulse: Sanofi, Bristol-Myers Squibb Gain On Earnings, Valneva-Pfizer Tout Positive Lyme Disease Vaccine Data, UNITY Biotech Restructures
    Here's a roundup of top developments in the biotech space over the last 24 hours. 
    Via Benzinga
    The Daily Biotech Pulse: Big Pharma Earnings Prove Lackluster, Mersana Inks $1B ADC R&D Deal, Syros Gets Orphan Drug Designation
    Here's a roundup of top developments in the biotech space over the last 24 hours: 
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
    Good morning, trader! We're starting off another day of trading with a breakdown of the biggest pre-market stock movers for Thursday! 
    Via InvestorPlace
    < Previous 1 2
    ...
    4 5 6 7 8 9 10 11 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.